A cutting-edge selection of molecular diagnostic tools designed to assist laboratories in identifying and characterizing nucleic acids for precise detection of pathogens.
SARS-CoV-2 is a top concern for patients and clinicians, but several respiratory pathogens can cause nearly indistinguishable symptoms. The FDA De Novo authorized BioFire RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19, influenza, RSV, and many others.
Pneumonia patients are frequently over-treated with antibiotics because it is difficult to quickly identify the pathogen responsible for their symptoms. The BioFire Pneumonia Panel delivers fast, accurate pathogen identification in about one hour, which may allow physicians to put patients on appropriate therapy quicker.
With integrated sample preparation, amplification, detection, and analysis, the BIOFIRE System uses multiplex PCR technology to simultaneously test for a comprehensive grouping of targets in about an hour. We test at the molecular level to deliver results that are fast, accurate, and comprehensive.
With integrated sample preparation, amplification, detection, and analysis, the BIOFIRE System uses multiplex PCR technology to simultaneously test for a comprehensive grouping of targets in about an hour. We test at the molecular level to deliver results that are fast, accurate, and comprehensive.
SARS-CoV-2 is a top concern for patients and clinicians, but several respiratory pathogens can cause nearly indistinguishable symptoms. The FDA De Novo authorized BioFire RP2.1 Panel is a frontline test to help clinicians quickly diagnose respiratory infections, including COVID-19, influenza, RSV, and many others.
Pneumonia patients are frequently over-treated with antibiotics because it is difficult to quickly identify the pathogen responsible for their symptoms. The BioFire Pneumonia Panel delivers fast, accurate pathogen identification in about one hour, which may allow physicians to put patients on appropriate therapy quicker.
With integrated sample preparation, amplification, detection, and analysis, the BIOFIRE System uses multiplex PCR technology to simultaneously test for a comprehensive grouping of targets in about an hour. We test at the molecular level to deliver results that are fast, accurate, and comprehensive.
With integrated sample preparation, amplification, detection, and analysis, the BIOFIRE System uses multiplex PCR technology to simultaneously test for a comprehensive grouping of targets in about an hour. We test at the molecular level to deliver results that are fast, accurate, and comprehensive.